Dow Up 1.13% Nasdaq Up 1.41%

NuPathe, Inc. (PATH)

-NasdaqGM
4.25 0.00(0.00%) Feb 21
Prev Close:4.25
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:5.00
Beta:2.87
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.57 - 4.49
Volume:0
Avg Vol (3m):668,474
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.89
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PATH 0.00%N/A
GSKUp 0.78%109.36B
MRKUp 1.10%167.14B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :N/A
Quarterly EPS Est (Dec-13) :N/A
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NuPathe Inc., a specialty pharmaceutical company, focuses on the development and commercialization of branded therapeutics for neurological and psychiatric disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback